Stay updated on Balstilimab and Zalifrelimab in Cervical Cancer Clinical Trial
Sign up to get notified when there's something new on the Balstilimab and Zalifrelimab in Cervical Cancer Clinical Trial page.

Latest updates to the Balstilimab and Zalifrelimab in Cervical Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedNew revision entry Revision: v3.5.4 was added to the study's record history, replacing Revision: v3.5.3. This update reflects a version-history change rather than a substantive modification to the study details.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedUpdate the ClinicalTrials.gov page revision/version indicator from **v3.5.2** to **v3.5.3**, reflecting a site-level release rather than a modification to the study’s documented information.SummaryDifference0.1%

- Check41 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed.SummaryDifference0.1%

- Check70 days agoChange DetectedThe page now displays Revision: v3.5.0, replacing the previous Revision: v3.4.3.SummaryDifference0.1%

- Check77 days agoChange DetectedA new revision entry (v3.4.3) was added and the previous revision (v3.4.2) was removed from the study record history.SummaryDifference0.1%

- Check106 days agoChange DetectedA new revision entry v3.4.2 has been added to the study record history, and the v3.4.1 entry has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Balstilimab and Zalifrelimab in Cervical Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Balstilimab and Zalifrelimab in Cervical Cancer Clinical Trial page.